Innovative Medical Device Coherex Medical develops a unique device aimed at treating atrial fibrillation patients at risk for stroke, presenting a differentiated product opportunity in the cardiology and stroke prevention markets.

Strategic Acquisition The company's acquisition by Biosense Webster in 2015 enhances its market credibility and provides access to a broader customer base, facilitating potential upselling and partnership opportunities.

Growth Funding With $17 million in funding and revenue ranging from 1 to 10 million dollars, Coherex is positioned for targeted market penetration, especially in specialty medical devices for stroke prevention.

Technology Stack Utilizing modern web and analytics technologies like TrackJS and Piwik suggests an emphasis on quality control and data-driven decision making, which can be appealing to hospital systems prioritizing reliable medical devices.

Market Positioning Operating in a space with large competitors like Abbott, Medtronic, and Boston Scientific, Coherex offers an innovative niche product that could be attractive to healthcare providers seeking effective, user-friendly stroke prevention solutions.